Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery

ClinicalTrials.gov ID: NCT01361568

Public ClinicalTrials.gov record NCT01361568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Randomized, Double Blind, Placebo Controlled Study to Evaluate the Analgesic Efficacy and Safety of Intravenous CR845 Dosed Preoperatively and Postoperatively in Patients Undergoing a Laparoscopic Hysterectomy

Study identification

NCT ID
NCT01361568
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cara Therapeutics, Inc.
Industry
Enrollment
203 participants

Conditions and interventions

Interventions

  • CR845 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2011
Primary completion
Mar 31, 2012
Completion
Mar 31, 2012
Last update posted
May 28, 2014

2011 – 2012

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
Shoals Clinical Research Associates Florence Alabama 35630
Horizon Research Group Mobile Alabama 36606
Wilmax Mobile Alabama 36608
Drug Research and Analysis Corp Montgomery Alabama 36106
Shoals Medical Trials, INC Sheffield Alabama 35660
Precision Clinical Trials Phoenix Arizona 85032
Woodland Healthcare California Clinical Research, Inc Davis California 95616
Olive View-UCLA Medical Center Sylmar California 91342
Visions Clinical Research Boynton Beach Florida 33472
Riverside Clinical Research Edgewater Florida 32132
University of Miami, Dept of Miami Florida 33136
Cypress Medical Research Wichita Kansas 67226
Cooper University Hospital Camden New Jersey 08103
Duke University Durham North Carolina 27710
Ohio State University Medical, Dept of Anesthesia Columbus Ohio 43210
Palmetto Clinical Research, Greenville South Carolina 29615
Chattanooga Medical Research Chattanooga Tennessee 37404
Texas Health Care, PLLC Fort Worth Texas 76104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01361568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2014 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01361568 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →